Asian Spectator

Men's Weekly

.

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

  • Written by PR Newswire Asia - Asian Spectator
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

MELBOURNE, Australia, Dec. 7, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces positive topline results from the Phase II OPALESCENCE investigator-initiated trial (IIT) of its carbonic anhydrase IX (CAIX)-targeting positron emission tomography (PET) imaging candidate, TLX250-CDx (89Zr-DFO-girentuximab...

Magazine

Understanding the Divorce Process: A Step-by-Step Guide for Families

Divorce can feel overwhelming, especially when emotions run high and the future seems uncertain. During these struggles, many people seek help from family lawyers, but having a working understanding...

Tren ‘podcast’ politik: Sarana informasi publik dan ruang klarifikasi politikus

(Podcast Mahfud MD/Youtube)● ‘Podcast’ yang membahas isu politik kini makin populer di kalangan audiens muda.● Bagi politikus, ‘podcast’ bisa menjadi wadah klarifik...

Mitos, mistis, dan masa depan pengetahuan lokal

CC BYDi banyak tempat di Indonesia, mitos bukan sekadar dongeng pengantar tidur atau kisah seram penuh mistis. Ia lahir dari upaya masyarakat untuk memahami dunia di sekitarnya, mulai dari bagaimana m...